When people live longer with chronic myeloid leukemia thanks to new drugs, doctors start noticing side effects that weren’t obvious before. One big concern is how these treatments affect weight and body fat over the years. A study looked back at adults with this type of leukemia who took a daily pil
TKIs, or Tyrosine Kinase Inhibitors, are making waves in the treatment of retinal diseases. These diseases, like diabetic retinopathy, are a big deal. They affect millions of people worldwide. TKIs are stepping up as a strong alternative to the usual protein-based treatments. These treatments target
Finding reliable ways to predict how metastatic kidney cancer patients will respond to treatment is a big deal. Doctors need this info to decide on the best care plan. One thing they're looking at is the glucose-to-lymphocyte ratio (GLR). This is like a sugar to immune cells ratio. A Turkish group c
Imagine you're living in Ethiopia and dealing with chronic myeloid leukemia (CML). This isn't just about staying alive; it's about living well. But how do patients in low-income countries like Ethiopia fare compared to those in wealthier nations? That's what researchers set out to find. They focuse
